AI governance for healthcare and life sciences, built for the decisions that actually carry consequence.
When the system is wrong, and the consequences are real, the question is whether anyone is prepared for that moment.
Advising pharmaceutical sponsors, health systems, AI vendors, and their boards on the governance, liability, and implementation decisions that determine whether AI deployment holds up under scrutiny.
Founded by a physician, attorney, and healthcare AI founder.
Organizations deploying AI in healthcare and other regulated industries almost always have a governance policy. What they don't have is the operational and technical infrastructure to act on it when something goes wrong. The policy lives in a document and the AI runs in production, and nobody has built the bridge between them.
Tercet Advisory closes that gap. We bring clinical, legal, and AI product development experience together in a single practice, which allows us to see the full topology of a problem rather than the fragment visible from any single discipline.
We help organizations build the operational architecture that makes governance real, from responsibility mapping and liability structuring to the design and implementation of the technical systems that embed oversight into workflows, decision pipelines, and human accountability mechanisms. The work moves from boardroom to codebase because that is where governance lives or dies.
Where We Work
Healthcare AI governance. Responsibility migration, clinical workflow oversight, and the monitoring infrastructure that makes AI accountability operational.
Enterprise AI risk and implementation. Stress-testing governance against realistic failure scenarios and building the technical systems that close the gap between policy and production.
Vendor liability advisory. Helping AI companies understand how their product architecture creates legal exposure, and building the safeguards that make their position defensible.
Board and investor AI advisory. Translating AI risk into fiduciary language for boards, audit committees, and private equity firms evaluating portfolio companies with AI exposure.
If your organization is deploying AI whose consequences affect patients, policyholders, or regulated populations, and the governance feels thinner than the ambition, we should talk.
Reach us at nseshadri@tercetadvisory.com or through the contact page.